Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
INSILICO Soars 17% as AI Framework for Drug Target Discovery Makes New Progress
Recommend 11 Positive 9 Negative 7 |
||||
|
||||
|
INSILICO (03696.HK) opened up 0.08% this morning (20th) and once peaked at HKD71.4. It last traded at HKD71.3, up 17.27%, with a volume of 6.2793 million shares, involving HKD426 million. The company announced that it had integrated its previously launched Target Identification Pro (TargetPro) and Target Identification Benchmark (TargetBench 1.0) into a framework that can further validate druggability. According to the research results recently published by INSILICO in Scientific Reports, this framework delivered outstanding results in both benchmark testing and real-world target discovery workflows, further demonstrating its value as a standardized foundation for AI-driven target identification. In addition, TIGERMED (03347.HK) has signed a strategic cooperation agreement with INSILICO, under which the two parties will engage in long-term strategic collaboration on clinical research for innovative drug products, leveraging AI to accelerate and enhance the efficiency of drug development. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
